About 10 results found for searched term "Ala-Ala-OMe" (0.134 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M50632 | Ala-Ala-OMe | Others |
| Ala-Ala-OMe is adipeptide derivative. | ||
| M52640 | Ala-Ala-Pro-Val-chloromethylketone | Elastase |
| Ala-Ala-Pro-Val-chloromethylketone is an irreversible human neutrophil elastase (NE) inhibitor for use in the study of chronic inflammatory airway diseases. | ||
| M3965 | Homoharringtonine | Alkaloids |
| Omacetaxine mepesuccinate,HHT | ||
| Homoharringtonine is a cephalotaxine alkaloid which inhibits the formation of diphenylalanine and acetylphenylalanyl-puromycin in liver ribosomes. | ||
| M4031 | Talatisamine | Potassium Channel |
| Talatisamine isa kind of aconite alkaloid, which isa specific K+ channel blocker. Talatisamine attenuated the neurotoxicity of beta-amyloid oligomers to cultured cortical neurons. | ||
| M7728 | Cytochalasin D | Actin-Related Protein |
| Zygosporin A; NSC 209835 | ||
| Cytochalasin D (Zygosporin A) is a cytopermeable actin polymerization inhibitor derived from fungi, which inhibits g-actin -- Cofilin interaction by binding g-actin. Cytochalasin D can also inhibit the binding of Cofilin to F-actin, reduce the release of exosomes and induce YAP phosphorylation. | ||
| M28356 | Xanomeline oxalate | AChR/AChE |
| LY246708 oxalate | ||
| Xanomeline oxalate (LY246708 oxalate) is a potent and selective muscarinic receptor agonist (SMRA) and stimulates phosphoinositide hydrolysis in vivo. Xanomeline oxalate can be used for the research of Alzheimer’s disease. | ||
| M41008 | Val-Ala-PABC-Exatecan | Drug-Linker Conjugates for ADC |
| Val-Ala-PABC-Exatecan is a Drug-Linker Conjugates for ADC, consiting of a cleavable Tesirine linker (Val-Ala-PABC) and Exatecan (topoisomerase I inhibitor). | ||
| M49949 | LDN-211904 oxalate | Ephrin Receptor |
| LDN-211904 oxalate is a potent and selective EphB3 inhibitor with an IC50 of 0.079 µM.LDN-211904 oxalate showed good metabolic stability in mouse liver microsomes.LDN-211904 oxalate was shown to be effective in inhibiting STAT3-activated CSC stemness in combination with cetuximab. | ||
| M52628 | D-Ala-D-Ala | Metabolite/Endogenous Metabolite |
| D-Ala-D-Ala constitutes the terminus of the peptide part of the peptidoglycan monomer unit and is involved in the transpeptidation reaction as the substrate. | ||
| M55214 | Azalamellarin N | Pyroptosis |
| AZL-N | ||
| Azalamellarin N is an inhibitor of pyroptosis and has different inhibitory effects on different pyroptosis inducers. Azalamellarin N inhibits pyroptosis by targeting molecules that act upstream of NLRP3 inflammasome activation, rather than directly targeting components of the NLRP3 inflammasome. | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
